The effectiveness and safety of higher doses of omalizumab in patients with chronic spontaneous urticaria: Real-life data from a retrospective cohort study

---

Atıf İçin Kopyala

SALMAN A., CÖMERT E.

24th World Congress of Dermatology, 10 - 15 Haziran 2019

• Yayın Türü: Bildiri
• Marmara Üniversitesi Adresli: Evet